$227.00+$3.05 (+1.36%)as of market close, Aug 13, 2026
☾ After hours:$227.12+0.00%3:59 PM ET
ALNY — Alnylam Pharmaceuticals Inc. stock price, chart and key statistics
Key stats#
Price data
- Price
- $227.00
- Change YTD
- -42.91%
- Market cap
- 30.4B
- Enterprise value
- 28.9B
- Shares outstanding
- 133.8M
- 52W low
- $197.81
- 52W high
- $495.55
- From 52W high
- -54.19%
- From 52W low
- +14.76%
- 52W range
- 10%
- Beta
- 0.29
Volume
- Rel volume
- 0.58×
- 30D volume
- 2.1M
- 30D $ vol
- 528.1M
Fundamentals
- Sales (ttm)
- 4.8B
- Sales/share
- $35.90
- EPS (ttm)
- $5.33
- FCF (ttm)
- 819.9M
- FCF/share
- $6.13
- Book value/share
- $10.12
- Net margin
- 15.26%
- ROE
- 54.14%
- ROA
- 13.19%
- Current ratio
- 3.05
Growth (CAGR, ttm) · 10Y
- Sales
- +62.74%
- Net income
- n/a
- FCF
- n/a
- Shares
- +4.55%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- n/a
- Sales/share
- +55.34%
- FCF/share
- n/a
- Book value/share
- -2.33%
- Price
- +11.85%
- Total return
- +11.85%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- 42.6×
- Fwd P/E
- 17.2×
- 6.3×
- 22.4×
- 37.0×
- EV/EBITDA (fy)
- 27.4×
- EV/Sales (ttm)
- 6.0×
- 2.70%
- -2.08%
- -2.08%
- 0.00%
- 0.00%
Vs own 10Y history
- P/S
- 0th
- P/B
- 61st
Bar = where today's multiple sits in ALNY's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return#
1D
+1.36%
1W
+5.03%
1M
-18.68%
3M
-22.12%
YTD
-42.91%
1Y
-47.20%
5Y
+17.07%
Financial statements
Open full ALNY financials →Related Health Care#
1MAlnylam Pharmaceuticals Inc. (ALNY) trades at $227.00 with a live price and an interactive chart covering 22+ years of daily price history, plus key valuation metrics. ChartRow also publishes ALNY's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full ALNY financial statements →